Eli Lilly is a leader in one of today’s biggest growth markets: weight loss drugs. The company recently won approval for an ...

The National Psoriasis Foundation has issued a detailed primer supporting GLP-1 receptor agonists as an adjunct therapy for psoriasis in patients with metabolic comorbidities. Evidence shows these ...

People taking semaglutide, the active ingredient in Ozempic and Wegovy, were 44% less likely to be treated for depression and ...

Ashley Graham criticises GLP-1 drugs and Ozempic trend, calling it a 'smack in the face' to body positivity in Hollywood and fashion.

A Gujarat man’s unsupervised semaglutide use led to medullary thyroid cancer, highlighting the dangers of weight-loss ...

Ashley Graham is not happy with what the prevalence of GLP-1 drugs is doing to body positivity. The popular plus-size model is the cover star of Marie Claire’s latest Motherhood Issue, and she ...

GLP-1 drugs like semaglutide—best known for treating diabetes and driving weight loss under the brand names Ozempic and ...

Ashley Graham calls the rise of GLP-1 weight loss shots disheartening as she vows to continue advocating for plus-size women ...

Mounjaro and Zepbound are driving Eli Lilly's earnings sharply higher. Foundayo looks like another top-seller. Eli Lilly's ...

The study found that hair loss was strongest among people who were taking higher doses of GLP-1s for weight loss.